Associate Professor of Clinical Medicine
Director, Melanoma/Sarcoma Program
Originally from Southern California, Dr. Lee Cranmer completed his medical degree (MD) and a doctorate (PhD) in biology at the University of California, San Diego. He then completed an internal medicine residency at the Mayo Clinic in Rochester, Minnesota.
Dr. Cranmer came to The University of Arizona Cancer Center in 2001 to undertake advanced fellowship training in medical oncology. After completing his fellowship, Dr. Cranmer joined the faculty of The University of Arizona Cancer Center, where he remains today. He is board certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology.
Dr. Cranmer is a medical oncologist. He evaluates and treats patients with complicated and advanced forms of skin cancer, including metastatic melanoma. He also treats adult patients with bone and soft tissue sarcomas. His melanoma interests have led him to be interested in the multi-disciplinary management for patients with brain metastases (spread of cancerous tumors to the brain). Dr. Cranmer also practices general internal medicine, general hematology and inpatient adult bone marrow/stem cell transplant.
Dr. Cranmer conducts both therapeutic and non-therapeutic clinical research in melanoma and sarcomas. In both areas, he maintains an extensive panel of active therapeutic clinical trials for patients afflicted with these disorders. He is working to develop clinical trials native to the Arizona Cancer Center in the areas of melanoma and brain metastasis management. In the laboratory, Dr. Cranmer’s research examines novel drugs to treat melanoma and sarcomas and biomarkers of response and prognosis.
Cranmer LD, Jeter JM, Hersh EM. (2009) Metastasis in Melanoma: Therapy of Limited Central Nervous System Disease. (Submitted to Melanoma Research.)
Dr. Cranmer collaborates closely in both clinical work and research with other members of the multi-disciplinary Cutaneous Oncology Program, the clinical division of the Skin Cancer Institute and Sarcoma Oncology Clinic staff members. He also collaborates with laboratory-based researchers at the Arizona Cancer Center.
Externally, Dr. Cranmer has on-going collaborations with a number of Arizona and non-Arizona-based researchers. He is additionally a member of the Southwest Oncology Group, a National Cancer Institute-funded cancer clinical research group.
- 2001–Present Arizona Board of Medical Examiners, #29291
- 1999–Present Drug Enforcement Administration Certificate
- 2001–11 Board Certified in Internal Medicine
- 2005–14 Board Certified in Medical Oncology
- Arizona Cancer Center, Therapeutic Development Section—Associate Member
- American College of Physicians (ACP)—Member
- American Society of Clinical Oncology (ASCO)—Member
- American Association for Cancer Research (AACR)—Member
- American Association of Immunologists (AAI)—Member
- Southwest Oncology Group (SWOG), Melanoma Committee—Member
- Children’s Clinics for Rehabilitative Services (CCRS)—Affiliate
- Connective Tissue Oncology Society (CTOS)—Member
- Arizona Cancer Center Scientific Review Committee—Member
- Arizona Cancer Center Space Committee—Alternate Member
- 1992-97 Life & Health Insurance Medical Research MD/PhD Scholar
- 1989 Student Award, Liverpool School of Tropical Medicine
- 1989-98 National Research Service Award
- 2005 Reviewer, Cancer Immunology and Immunotherapy
- 2006 Reviewer, Neuropathology and Applied Neurobiology
- 2007 Clinical Faculty for Cancer Biology Graduate Program
- 2009 Certificate of Appreciation to the “Bench to Bedside” Open House
- 2009 Reviewer, Cancer
- 2009 Reviewer, Melanoma Research
- 2009 Reviewer, International Journal of Cancer